[Prognosis and treatment of pneumococcal meningitis in infancy (apropos of 6 cases)].
D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002701:Chloramphenicol / Q000008:administration & dosage; D003638:Deafness / Q000209:etiology; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008586:Meningitis, Pneumococcal / Q000134:cerebrospinal fluid / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D009461:Neurologic Manifestations; D010406:Penicillins / Q000008:administration & dosage / Q000009:adverse effects; D010477:Perfusion; D011379:Prognosis; D013307:Streptomycin / Q000008:administration & dosage; D013411:Sulfadiazine / Q000008:administration & dosage; D013416:Sulfamerazine / Q000008:administration & dosage; D013449:Sulfonamides / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D010406:Penicillins; D013449:Sulfonamides; D013411:Sulfadiazine; D002701:Chloramphenicol; D013416:Sulfamerazine; D013307:Streptomycin
Pronostic et traitement de la méningite à pneumocoques du premier age (à propos de six observations)